Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study-Reference-Cited by-同舟云学术

Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study

Published:2004-10 Issue:1 Volume:95 Page:127-132
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Umesaki Naohiko,Fujii Tuneo,Nishimura Ryuichiro,Tanaka Tetsuji,Nishida Masato,Fushiki Hiroshi,Takizawa Ken,Yamamoto Kaichiro,Hasegawa Kazuo,Izumi Rikuichi

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference29 articles.

1. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study;Benedetti-Panici;J. Clin. Oncol.,2002

2. Cisplatin in advanced cancer of the cervix: an update;Alberts;Semin. Oncol.,1998

3. The platinum compounds and paclitaxel in the management of patients with carcinoma of the cervix;Thigpen;Semin. Oncol.,1995

4. The role of paclitaxel in the management of patients with carcinoma of the cervix;Thigpen;Semin. Oncol.,1997

5. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study;Alberts;J. Clin. Oncol.,1987

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TREATMENT OUTCOME AND TOXICITY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY VERSUS CONCOMITANT CHEMORADIATION ALONE IN LOCALLY ADVANCED CERVICAL CARCINOMA: A COMPARATIVE STUDY;Asian Journal of Pharmaceutical and Clinical Research;2022-07-07

2. Cervical Cancer;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13

3. Tumor-targeted co-delivery of mitomycin C and 10-hydroxycamptothecin via micellar nanocarriers for enhanced anticancer efficacy;RSC Advances;2015

4. Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl;Environmental Toxicology;2014-01-29

5. Developments in the systemic treatment of metastatic cervical cancer;Cancer Treatment Reviews;2013-08